Skip to Main Content

Featured Stories: Hematology

Humanized Mice Lead to Breakthroughs in Blood Cancers

Humanized mice created at Yale are opening new avenues of research into cancers caused by disorders in the production of blood, such as acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS).

Tasha: Leukemia Survivor

Tasha was diagnosed with acute promyelocytic leukemia, a rare, quick moving subtype of AML where immature white blood cells accumulate in the bone marrow.

Transforming Research for Blood Malignancies

Recent research and medical practice address not only AML but also lesser-known blood malignancies such as MDS and MPNs.

New Immunotherapy for Blood Cancers

An innovative new immunotherapy program for patients with certain blood cancers has launched. Chimeric Antigen Receptor (CAR) T-cell therapy reprograms a patient’s own T-cells to target tumor antigens.

A Pathway Towards Better Therapies for T-Cell Lymphoma

Two scientists at Yale are working to change the outcomes for Angioimmunoblastic T-cell lymphoma (AITL), a rare, fast-growing cancer typically diagnosed at an advanced stage.

Collaboration of Care to Battle a Rare Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare cancer involving the skin, bone marrow, and lymph nodes.

Innovative Care and Brother Love Team Up

When Marc St. Martin was diagnosed with cutaneous T-cell lymphoma (CTCL), he had no way of knowing the impact it would have throughout his family.

Love Knows no Bounds, Not Even Cancer

At the age of 23, Josh Scussell was starting his life, and like most people in their early twenties, cancer was the last thing on his mind.

Denise: Hematologic Cancer Survivor

Denise Iorio was faced with two treatment options when she was diagnosed with myelodysplastic syndrome (MDS), she could take medication to control symptoms, or undergo a stem cell transplant.

Jody: Leukemia Survivor

The team at the Survivorship Clinic helped Jody understand that you are not the same person you were the day before you got diagnosed.

John: Leukemia Survivor

After receiving treatment for melanoma, a bone marrow biopsy confirmed that John had another cancer: acute myeloid leukemia.